Table 3.
Age Group | Sex | Screened | HCVAb+ | Prevalence | CI 95% | HCV RNA+ | Prevalence | CI 95% |
---|---|---|---|---|---|---|---|---|
30–39 | F | 559 | 1 | 0.179 | 0.005–0.993 | – | – | – |
M | 274 | 3 | 1.100 | 0.226–3.166 | – | – | – | |
40–49 | F | 1058 | 5 | 0.473 | 0.154–1.10 | 1 | 0.095 | 0.0024–0.525 |
M | 545 | 3 | 0.550 | 0.114–1.600 | – | – | – | |
≥50 | F | 518 | 7 | 1.350 | 0.545–2.764 | 1 | 0.193 | 0.0049–1.07 |
M | 336 | 12 | 3.448 | 1.645–5.782 | 3 | 0.893 | 0.185–2.59 |